Tracking the Evolution of Digital Therapeutics, Its Benefits and Challenges

Digital therapeutics is both new and old. It is new in that it is a novel form of care delivery with the capacity to solve problems in healthcare, but it is also old in that its building blocks are technologies that many practices already use. Megan Coder, executive director of Digital Therapeutics Alliance, walks through what digital therapeutics is, the challenges it faces in reimbursement and regulations, and its future in our rapidly changing healthcare environment.